Legal Analysis: the Statutory Reach of the New DOJ Healthcare Fraud Task Force

The Expanded Scope of 18 U.S.C. § 1347 and Conspiracy Liability Under § 1349

In my 25 years as a federal prosecutor, I have never seen a more aggressive expansion of statutory reach than what the new DOJ Healthcare Fraud Task Force now brings to bear under 18 U.S.C. § 1347, the federal healthcare fraud statute. This provision criminalizes any scheme to defraud a healthcare benefit program, and the task force has made clear that they interpret "healthcare benefit program" to include virtually any private insurance plan, employer-sponsored health plan, or government program that pays for healthcare services. The real teeth of this enforcement effort, however, lie in 18 U.S.C. § 1349, which punishes conspiracy to commit healthcare fraud with the same penalties as the underlying offense—up to 10 years per count, or 20 years if the violation results in serious bodily injury. What many defense attorneys fail to appreciate is that the government no longer needs to prove that a defendant actually submitted a false claim; merely agreeing to participate in a scheme that could result in false claims is sufficient for conviction under § 1349. This means that hospital administrators, marketing executives, and even referring physicians who never touched a billing code can face substantial prison time if the government can show they knew about the fraudulent arrangement and took some action in furtherance of it. The task force's emphasis on "hub-and-spoke" conspiracy indictments, where one central figure is charged alongside numerous peripheral participants, dramatically increases the exposure for every professional in the healthcare delivery chain.

The Intersection of the Anti-Kickback Statute and Criminal Healthcare Fraud

The new task force has fundamentally changed how federal prosecutors view the Anti-Kickback Statute, codified at 42 U.S.C. § 1320a-7b(b), transforming what was once a regulatory compliance issue into a primary tool for criminal healthcare fraud prosecutions. Under this statute, it is a felony to knowingly and willfully offer, pay, solicit, or receive remuneration in exchange for referrals of items or services covered by a federal healthcare program, and the task force now routinely charges AKS violations as predicate offenses under 18 U.S.C. § 1347. In my experience, the government's preferred strategy is to allege that any kickback arrangement—whether a sham consulting agreement, an inflated lease payment, or a free "marketing" service—renders all resulting claims to Medicare or Medicaid "false" under the fraud statute because the claims were tainted by illegal remuneration. The most dangerous development is the government's aggressive interpretation of the "knowing" standard, which now includes conscious avoidance or willful blindness, meaning that a defendant who deliberately ignores red flags about a referral arrangement can still be convicted even without direct evidence of intent. Defense counsel must also contend with the fact that the task force is coordinating with the Office of Inspector General and the Centers for Medicare & Medicaid Services to obtain administrative exclusion orders concurrently with criminal charges, effectively shutting down a defendant's ability to practice or operate a healthcare business before trial. For clients in the pharmaceutical, medical device, or hospital sectors, I advise immediate engagement of counsel to conduct a privileged internal review of all referral relationships and compensation arrangements, because the task force's data analytics capabilities allow them to identify statistical outliers in billing patterns that often trigger investigations.

Civil False Claims Act Exposure and the Coordination with Criminal Prosecutions

One of the most overlooked aspects of the new task force's statutory reach is its seamless coordination between criminal healthcare fraud investigations and parallel civil False Claims Act proceedings under 31 U.S.C. § 3729, which creates devastating financial exposure for defendants who survive a criminal trial. The FCA imposes treble damages and mandatory civil penalties of $13,946 to $27,894 per false claim (adjusted annually for inflation), and when combined with criminal restitution orders under 18 U.S.C. § 3663A, a single healthcare fraud scheme can result in total liability exceeding the defendant's net worth many times over. In my practice, I have seen the government use the criminal discovery process to build a civil case simultaneously, taking advantage of the lower preponderance of the evidence standard in civil proceedings to secure judgments even when the criminal case fails to prove guilt beyond a reasonable doubt. The task force's memoranda of understanding with the Department of Health and Human Services and state Medicaid Fraud Control Units ensure that evidence gathered in a criminal investigation is immediately shared with civil attorneys, and the tolling agreements they offer during negotiations often pressure defendants into settling both criminal and civil exposure at once. What many healthcare executives do not understand is that the FCA's "reverse false claim" provision, which penalizes knowing retention of an overpayment, creates liability even when the original claim was accurate—if the defendant discovers an error and fails to report and repay within 60 days. This statutory framework, combined with the task force's aggressive use of qui tam relators who can receive 15-30% of the government's recovery, means that every healthcare provider must treat internal compliance audits as potential evidence in a future government investigation.

Practical Defense Strategies in the Age of the Healthcare Fraud Task Force

Given the breadth of the statutes now being enforced by the task force, the most critical defense strategy is to challenge the government's theory of scienter at the earliest possible stage, because the statutes require proof that the defendant acted "knowingly and willfully," which creates a constitutional floor that the government must meet. In my 25 years of practice, I have found that the most effective motions to dismiss under Federal Rule of Criminal Procedure 12(b)(3) focus on the government's failure to plead specific facts showing that a defendant had actual knowledge of the falsity of the claims or the illegality of the remuneration arrangement, rather than mere negligence or regulatory confusion. The task force's reliance on statistical outlier data and billing pattern analysis can be attacked through expert testimony under Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), because these methodologies often fail to account for legitimate clinical variations, patient acuity differences, or coding nuances that explain the alleged anomalies. Defense counsel should also aggressively pursue discovery under Brady v. Maryland, 373 U.S. 83 (1963), for any exculpatory evidence in the government's possession, particularly internal DOJ memoranda that may reveal the task force's targeting criteria or statistical thresholds that could demonstrate selective prosecution. Another underutilized tool is the Safe Harbor provisions under the Anti-Kickback Statute, 42 C.F.R. § 1001.952, which, if properly structured, can defeat the government's claim that remuneration was intended to induce referrals, and I have successfully used these regulations to obtain pre-indictment declinations for clients who had implemented compliant arrangements. Ultimately, the best defense is proactive: ensuring that every compensation arrangement, referral relationship, and billing practice is documented in writing with contemporaneous legal review, because the task force's statutory reach is only limited by the quality of the evidence they can gather.

Frequently Asked Questions

If you or your organization is facing a healthcare fraud investigation or has received a subpoena, civil investigative demand, or target letter from the DOJ Healthcare Fraud Task Force, immediate legal intervention is critical to preserve your rights and explore strategic options. In my 25 years as a federal prosecutor and now as a defense attorney, I have seen how early engagement with experienced counsel can mean the difference between a pre-indictment declination and a multi-count indictment that carries decades of potential imprisonment. I invite you to contact my office for a confidential consultation where we can review the specific facts of your case, assess your exposure under the statutes discussed in this article, and develop a proactive defense strategy tailored to your unique circumstances. Do not wait until charges are filed—the task force's coordination with federal agents means that evidence is being gathered against you even before you know you are a target. Call our firm today to schedule a private meeting and take the first step toward protecting your career, your license, and your freedom.